|
Neonatal Intensive Care Drug Manual
|
bet | 343/654 | Sana | 03.01.2022 | Hajmi | 1,5 Mb. | | #14803 |
Contraindications
|
Heart block or myocardial damage.
|
Precautions
|
Use with caution in renal impairment.
|
Drug Interactions
|
Concurrent use with paralysing agents may enhance neuromuscular blockade (e.g. succinylcholine, vecuronium, rocuronium, etc)
Concomitant use with aminoglycosides may cause neuromuscular weakness (respirator arrest).
|
Adverse Reactions
|
Hypotension, bradycardia and circulatory collapse with rapid infusion.
ECG changes (prolonged AV conduction time, sino-atrial block, AV block). Calcium chloride/calcium gluconate should be available to reverse adverse effects. Flushing, sweating, respiratory depression (particularly with higher plasma concentrations) abdominal distension, diarrhoea, urinary retention, CNS depression, muscle relaxation,
hyporeflexia.
|
Compatibility
|
Sodium chloride 0.9%, sodium chloride 0.45%/glucose 4%, glucose 5%, parenteral nutrition, glucose amino acid solution.
Y site: Aciclovir, amifostine, amikacin, ampicillin, aztreonam, bivalirudin, caspofungin, cefotaxime, cefoxitin, cefazolin, chloramphenicol, cisatracurium, dexmedetomidine, doripenem, esmolol, gentamicin, granisetron, heparin sodium, hydrocortisone sodium, succinate, labetalol, linezolid, metronidazole, milrinone, morphine sulfate, piperacillin-tazobactam (EDTA-free), potassium chloride, remifentanil, sodium nitroprusside, trimethoprim-sulfamethoxazole, vancomycin.
|
Incompatibility
|
Fat emulsion. Incompatible with soluble phosphates and with alkaline carbonates and, bicarbonates.
Y site: Aminophylline, amiodarone, anidulafungin, azathioprine, calcium chloride, calcium, salts, cefepime, ceftriaxone, ciprofloxacin, clindamycin, cyclosporin, dexamethasone, ganciclovir, haloperidol lactate, indometacin, methylprednisolone sodium succinate,
pentamidine, phosphate salts, sodium bicarbonate.
|
Stability
|
Change the IV preparation every 24 hours.,
|
Storage
|
Store at room temperature and protect from light.
|
|
|
| |